Ground Swell Capital’s PharmaCyte Biotech PMCB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.05K Buy
+1,032
New +$10.8K 0.02% 131
2026
Q2
– Sell
-607
Closed -$7.67K – 203
2026
Q1
$7.67K Buy
+607
New +$8.82K 0.02% 104

Other funds holding PMCB

Ground Swell Capital's PMCB Position: Q3 2026 in Review

Ground Swell Capital opened a new position in PharmaCyte Biotech (PMCB) in Q3 2026: 1,032 shares worth $8.05K. The stake represents 0.02% of the portfolio and ranks #131 among its holdings. This is a return to the name: Ground Swell Capital previously reported a position in PMCB as recently as Q1 2026.

Ground Swell Capital first reported a position in PMCB in Q1 2026 and has held it in 2 quarters since. 20 funds tracked by Wall St. Rank hold PMCB as of Q3 2026.

  • Ground Swell Capital held 1,032 shares of PharmaCyte Biotech worth $8.05K as of Q3 2026.
  • PharmaCyte Biotech was a new Ground Swell Capital position in Q3 2026.
  • PharmaCyte Biotech made up 0.02% of Ground Swell Capital's portfolio in Q3 2026, its #131 holding.
  • Ground Swell Capital first reported a position in PharmaCyte Biotech in Q1 2026 and has held it in 2 quarters since.
  • 20 funds tracked by Wall St. Rank held PharmaCyte Biotech as of Q3 2026.

Based on Ground Swell Capital's 13F filing for Q3 2026, filed 9 Nov 2026.